UK markets closed

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
141.66+0.95 (+0.68%)
As of 03:58PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts18181818
Avg. Estimate1.051.264.126.3
Low estimate0.270.913.114.78
High estimate1.621.515.518.52
Year ago EPS0.950.822.474.12
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts24232626
Avg. Estimate548.01M569.6M2.22B2.6B
Low estimate532.92M554M2.17B2.32B
High estimate581M619M2.37B3.78B
Year ago sales447.31MN/A1.89B2.22B
Sales growth (year/est)22.50%N/A17.80%17.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS0.780.971.141.01
Actual EPS0.950.821.440.42
Difference0.17-0.150.3-0.59
Surprise %21.80%-15.50%26.30%-58.40%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate1.051.264.126.3
7 days ago1.181.34.776.41
30 days ago1.191.314.86.29
60 days ago1.191.314.796.3
90 days ago1.161.284.736.4
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1117
Up last 30 days71347
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A16
Growth estimatesNBIXIndustrySector(s)S&P 500
Current qtr.10.50%N/AN/AN/A
Next qtr.53.70%N/AN/AN/A
Current year66.80%N/AN/AN/A
Next year52.90%N/AN/AN/A
Next 5 years (per annum)18.00%N/AN/AN/A
Past 5 years (per annum)12.02%N/AN/AN/A